Page last updated: 2024-08-24

lamivudine and Stevens-Johnson Syndrome

lamivudine has been researched along with Stevens-Johnson Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akakpo, AS; Bassowa, A; Dapam, AN; Kombaté, K; Laouali, AY; Mahamadou, G; Mensah, E; Mouhari-Toure, A; Pitché, P; Saka, B; Teclessou, JN	1
Cárden-Santana, MA; Carrillo-Díaz, T; Castillo-Sainz, R; Suárez-Lorenzo, I	1
Ahmed, YI; Chasela, CS; Chigwenembe, M; Ellington, SR; Fiscus, SA; Hoffman, IF; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; Kazembe, P; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, CM; Wiener, JB	1

Trials

1 trial(s) available for lamivudine and Stevens-Johnson Syndrome

Article	Year
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. The New England journal of medicine, 2010, Jun-17, Volume: 362, Issue:24 Topics: Adult; Anti-Retroviral Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Risk Factors; Stevens-Johnson Syndrome; Young Adult; Zidovudine	2010

Article

Year

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

The New England journal of medicine, 2010, Jun-17, Volume: 362, Issue:24

Topics: Adult; Anti-Retroviral Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Risk Factors; Stevens-Johnson Syndrome; Young Adult; Zidovudine

2010

Other Studies

2 other study(ies) available for lamivudine and Stevens-Johnson Syndrome

Article	Year
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report. Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:12 Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Gynecomastia; HIV Infections; Humans; Lamivudine; Male; Mucositis; Nevirapine; Reverse Transcriptase Inhibitors; Stevens-Johnson Syndrome	2018
Severe reaction to emtricitabine and lamiduvine: evidence of cross-reactivity. Contact dermatitis, 2016, Volume: 74, Issue:4 Topics: Anti-HIV Agents; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Patch Tests; Stevens-Johnson Syndrome	2016

Article

Year

Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.

Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:12

Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Gynecomastia; HIV Infections; Humans; Lamivudine; Male; Mucositis; Nevirapine; Reverse Transcriptase Inhibitors; Stevens-Johnson Syndrome

2018

Severe reaction to emtricitabine and lamiduvine: evidence of cross-reactivity.

Contact dermatitis, 2016, Volume: 74, Issue:4

Topics: Anti-HIV Agents; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Patch Tests; Stevens-Johnson Syndrome

2016